Abstract
Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Recent Patents on Biotechnology
Title: Recent Patents on Influenza Vaccines
Volume: 1 Issue: 3
Author(s): Yu-Chen Hu and Chi-Yuan Chen
Affiliation:
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Abstract: Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Export Options
About this article
Cite this article as:
Hu Yu-Chen and Chen Chi-Yuan, Recent Patents on Influenza Vaccines, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330192
DOI https://dx.doi.org/10.2174/187220807782330192 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Application of Proteomics in Neurology
Current Proteomics Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Current Medicinal Chemistry Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
Current Cancer Drug Targets Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Current Pharmaceutical Design The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Endocrine, Metabolic & Immune Disorders - Drug Targets β -Glucans and their Applications in Cancer Therapy: Focus on human studies
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Stimuli Responsive Hydrogel Drug Delivery System
Recent Patents on Drug Delivery & Formulation Induction of Senescent-Like Growth Arrest as a New Target in Anticancer Treatment
Current Cancer Drug Targets Posterior Reversible Encephalopathy Syndrome in Leukemic Children: A Sensitive Issue
Current Drug Safety Metabolic Action of Thyroid Hormones: Insights from Functional and Proteomic Studies
Current Proteomics Oncogene Suppression by Small Interfering RNAs
Current Pharmaceutical Biotechnology Antibacterial and Antifungal Screening of Novel α-amino Acid Conjugated Bile Acid Derivatives
Current Bioactive Compounds A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents
Mini-Reviews in Medicinal Chemistry Novel Antimicrobial Agents for the Management of Maxillofacial and Neck Infections
Recent Patents on Anti-Infective Drug Discovery Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
Current Radiopharmaceuticals Synthesis and Biological Evaluation of a Series of 2-(Substitutedphenyl) benzothiazoles
Medicinal Chemistry